Pasithea - KTTA Operatsion marja

KTTA (pasitheaclinics.com) - kompaniyaning tovar belgisi

Pasithea Therapeutics (KTTA) neyrofibromatozga qarshi dori vositalarini ishlab chiqishni depressiyani davolash uchun ketamin terapiyasi markazlarini ochish bilan birlashtiradi. Ishlab chiqarish shartnomaviy ishlab chiqarish liniyalariga va moddalarni chiqarish uchun steril izolyatorlarga tayanadi. Foizlar va soliqlar to'lanishidan oldingi operatsion foyda marjasidagi tendentsiya, bunda 0.00 darajasi joriy qiymat hisoblanadi, M&A salohiyatini va sezilarli kapital bilan qo'llab-quvvatlangan makrofag inhibitorlari klinik sinovlarining muvaffaqiyatini tasdiqlaydi.

Pasithea Therapeutics Corp (KTTA): Operatsion foyda normasi 04.07.2022dan 20.11.2026gacha

Pasithea Therapeutics Corp (KTTA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:pasitheaclinics.com
Pasithea Therapeutics Corp. asosiy tovari

Investorlar biznesning barqarorligini tekshirish va xarajatlarni boshqarish samaradorligini baholash uchun operatsion koeffitsientlardan foydalanadilar. EBIT marjasi tahlili moliyaviy majburiyatlar hisobga olinishidan oldin, asosiy operatsiyalardan olingan foyda ulushini tushumga nisbatan o'lchash imkonini beradi, bu esa Pasithea Therapeutics (KTTA) uchun uning ishlanmalarining ventyura tabiati va kichik molekulalarning erta bosqichdagi klinik sinovlari bilan bog'liq yuqori xarajatlar tufayli juda muhimdir.

Asosiy raqobatchilar

Sotuvning operatsion marjasi BIIB|NBIX: Operatsion foyda normasi|Operatsion rentabellik Regencell Bioscience Ltd (RGC)|Operatsion marja axsome.com (AXSM)|Operatsion marja ACAD (acadia-pharm.com)|XENE - Sotuvning operatsion marjasi|vikingtherapeutics.com - Operatsion marja|Supernus Pharma (SUPN) - Sotuvning operatsion marjasi|CPRX: Operatsion marja|Denali Therapeutics Inc. (DNLI) - Operatsion marja|Operatsion rentabellik Harmony Pharma|Operatsion rentabellik BHVN|Sotuvning operatsion marjasi AMLX (Amylyx Pharmaceuticals, Inc.)|Sotuvning operatsion marjasi Trevi Corp TRVI|Operatsion rentabellik praxismedicines.com PRAX|AVXL - Sotuvning operatsion marjasi|CeriBell EEG - Operatsion marja|Sotuvning operatsion rentabelligi prothena.com|Alector Therapeutics (ALEC) - Operatsion rentabellik|Annexon Biosciences Inc. - Operatsion foyda normasi|OMER (Omeros Corp) - Operatsion marja|Operatsion marja neurogene.com|Operatsion marja ACIU|VYGR - Sotuvning operatsion rentabelligi|Operatsion rentabellik Neumora Therapeutics Inc NMRA|Operatsion faoliyat rentabelligi Scilex Holding Co. (SCLX)|TVGN - Operatsion rentabellik|Sotuvning operatsion rentabelligi alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Sotuvning operatsion marjasi|IKT: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Cassava Sciences, Inc.|ASRT (assertiotx.com) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Coya (COYA)|VTGN - Sotuvning operatsion rentabelligi|Operatsion marja OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Sotuvning operatsion rentabelligi|cervomed.com - Operatsion marja|Operatsion foyda normasi ATHE (Alterity Therapeutics Limited)|CLNN: Operatsion marja|Sotuvning operatsion marjasi PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Relmada Therapeutics Inc RLMD|Operatsion rentabellik Annovis Bio Corporation (ANVS)|GRCE - Sotuvning operatsion rentabelligi|Operatsion rentabellik Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Sotuvning operatsion rentabelligi|NeuroSense Therapeutics, Ltd. - Operatsion marja|RVPH: Operatsion rentabellik|MTVA: Operatsion marja|NRXS - Operatsion faoliyat rentabelligi|HSDT (Helius Medical Technologies Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Passage Bio PASG|Operatsion rentabellik Neuphoria (NEUP)|Operatsion marja Minerva Neurosciences Corp (NERV)|Operatsion rentabellik Athira ATHA|Operatsion marja Addex ADXN|Alzamend - Operatsion marja|Sotuvning operatsion rentabelligi Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Operatsion rentabellik|Operatsion foyda bo'yicha marjinallik Cortigent, Inc. CRGT|Operatsion rentabellik Avenue Therapeutics, Inc.|Sotuvning operatsion marjasi BrainStorm Cell Therapeutics Inc. (BCLI)|Operatsion rentabellik Cara Therapeutics, Inc (CARA)|Operatsion rentabellik CHRO (Chromocell Therapeutics Corp.)|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi